Danaher Co. (DHR) Stake Boosted by Spinnaker Trust
Spinnaker Trust lifted its holdings in Danaher Co. (NYSE:DHR) by 4.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,156 shares of the conglomerate’s stock after purchasing an additional 133 shares during the period. Spinnaker Trust’s holdings in Danaher were worth $325,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of the company. FMR LLC boosted its stake in shares of Danaher by 10.3% in the 2nd quarter. FMR LLC now owns 21,011,026 shares of the conglomerate’s stock valued at $2,073,369,000 after buying an additional 1,963,116 shares during the period. Bank of Montreal Can raised its position in shares of Danaher by 113.3% during the 3rd quarter. Bank of Montreal Can now owns 1,069,328 shares of the conglomerate’s stock worth $116,195,000 after acquiring an additional 567,990 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD raised its position in shares of Danaher by 1.6% during the 3rd quarter. Sumitomo Mitsui Asset Management Company LTD now owns 57,244 shares of the conglomerate’s stock worth $6,220,000 after acquiring an additional 909 shares in the last quarter. Delaney Dennis R raised its position in shares of Danaher by 5.8% during the 3rd quarter. Delaney Dennis R now owns 15,875 shares of the conglomerate’s stock worth $1,726,000 after acquiring an additional 868 shares in the last quarter. Finally, Bartlett & Co. LLC raised its position in shares of Danaher by 187.2% during the 3rd quarter. Bartlett & Co. LLC now owns 1,611 shares of the conglomerate’s stock worth $175,000 after acquiring an additional 1,050 shares in the last quarter. Institutional investors and hedge funds own 77.79% of the company’s stock.
DHR has been the topic of several research analyst reports. Needham & Company LLC initiated coverage on Danaher in a research report on Wednesday, January 2nd. They set a “buy” rating and a $114.00 target price on the stock. Royal Bank of Canada reaffirmed a “hold” rating and set a $102.00 price target on shares of Danaher in a research report on Wednesday, December 19th. Robert W. Baird cut their price target on Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research report on Friday, October 19th. Finally, Cowen reaffirmed a “buy” rating and set a $110.00 price target on shares of Danaher in a research report on Monday, January 7th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $113.08.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. The business had revenue of $5.40 billion for the quarter, compared to analyst estimates of $5.33 billion. Danaher had a return on equity of 11.64% and a net margin of 13.33%. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 earnings per share. Research analysts forecast that Danaher Co. will post 4.78 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, January 25th. Stockholders of record on Friday, December 28th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.58%. The ex-dividend date of this dividend was Thursday, December 27th. Danaher’s payout ratio is currently 14.16%.
ILLEGAL ACTIVITY WARNING: “Danaher Co. (DHR) Stake Boosted by Spinnaker Trust” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://theolympiareport.com/2019/02/11/danaher-co-dhr-stake-boosted-by-spinnaker-trust.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Further Reading: What is a good rate of return for a mutual fund?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.